Mass Tort News
7 min read
Depo-Provera Litigation: FDA Warning Reshapes MDL as Cases Surpass 2,100
FDA adds meningioma warning to Depo-Provera label as MDL 3140 surpasses 2,100 cases. First bellwether trial set for December 2026.
Read
#meningioma
1 article with this tag